Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) infection in regions in which it is endemic, including Southern China and Southeast Asia. The high mortality rates of NPC patients with advanced and recurrent disease highlight the urgent need for effective treat...
Main Authors: | Pok Man Hau, Hong Lok Lung, Man Wu, Chi Man Tsang, Ka-Leung Wong, Nai Ki Mak, Kwok Wai Lo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00600/full |
Similar Items
-
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma
by: Tomokazu Yoshizaki, et al.
Published: (2023-12-01) -
Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01) -
Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
by: Krzysztof Wojtak, et al.
Published: (2019-05-01) -
Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01) -
Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events
by: Bo Zhao
Published: (2023-03-01)